- Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: a critical review and practical guidance. World J Hepatol. 2016;8:307–321. doi:10.4254/wjh.v8.i6.307.
- Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science. 2012;338:768–772. doi:10.1126/science.1224577.
- Ashrafian H. Hepcidin: the missing link between hemochromatosis and infections. Infect Immun. 2003;71:6693–6700.
- Daniels NA. Vibrio vulnificus oysters: pearls and perils. Clin Infect Dis. 2011;52:788–792. doi:10.1093/cid/ciq251.
- Yu W, Shen X, Pan H, et al. Clinical features and treatment of patients with Vibrio vulnificus infection. Int J Infect Dis. 2017;59:1–6. doi:10.1016/j.ijid.2017.03.017.
- Menon MP, Yu PA, Iwamoto M, et al. Pre-existing medical conditions associated with Vibrio vulnificus septicaemia. Epidemiol Infect. 2014;142:878–881. doi:10.1017/S0950268813001593.
- Payne SM, Mey AR, Wyckoff EE. Vibrio iron transport: evolutionary adaptation to life in multiple environments. Microbiol Mol Biol Rev. 2016;80:69–90. doi:10.1128/MMBR.00046-15.
- El Chaer F, Holtzman NG, Baer MR, et al. Sickle cell disease complicated by iron overload: an under-recognized risk factor for Vibrio vulnificus infection. Acta Haematol. 2018;139:199–200. doi:10.1159/000488754.
- Han F, Pu S, Hou A, et al. Characterization of clinical and environmental types of Vibrio vulnificus isolates from Louisiana oysters. Foodborne Pathog Dis. 2009;6:1251–1258. doi:10.1089/fpd.2009.0343.
- Baker-Austin C, Oliver JD. Vibrio vulnificus: new insights into a deadly opportunistic pathogen. Environ Microbiol. 2018;20:423–430. doi:10.1111/1462-2920.13955.
- Shapiro RL, Altekruse S, Hutwagner L, et al; Vibrio Working Group. The role of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988–1996. J Infect Dis. 1998;178:752–759. doi:10.1086/515367.
- Zhao H, Xu L, Dong H, et al. Correlations between clinical features and mortality in patients with Vibrio vulnificus infection. PLoS One. 2015;10:e0136019. doi:10.1371/journal.pone.0136019.
- Oliver JD. Vibrio vulnificus: death on the half shell. A personal journey with the pathogen and its ecology. Microb Ecol. 2013;65:793–799. doi:10.1007/s00248-012-0140-9.
- Kuo YL, Shieh SJ, Chiu HY, et al. Necrotizing fasciitis caused by Vibrio vulnificus: epidemiology, clinical findings, treatment and prevention. Eur J Clin Microbiol Infect Dis. 2007;26:785–792. doi:10.1007/s10096-007-0358-5.
- Ruppert J, Panzig B, Guertler L, et al. Two cases of severe sepsis due to Vibrio vulnificus wound infection acquired in the Baltic Sea. Eur J Clin Microbiol Infect Dis. 2004;23:912–915.
- Tacket CO, Barrett TJ, Mann JM, et al. Wound infections caused by Vibrio vulnificus, a marine Vibrio, in inland areas of the United States. J Clin Microbiol. 1984;19:197–199.
- Horseman MA, Surani S. A comprehensive review of Vibrio vulnificus: an important cause of severe sepsis and skin and soft-tissue infection. Int J Infect Dis. 2011;15:e157–e166. doi:10.1016/j.ijid.2010.11.003.
- Chen SC, Lee YT, Tsai SJ, et al. Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period. J Antimicrob Chemother. 2012;67:488–493. doi:10.1093/jac/dkr476.
- Trinh SA, Gavin HE, Satchell KJF. Efficacy of ceftriaxone, cefepime, doxycycline, ciprofloxacin, and combination therapy for Vibrio vulnificus foodborne septicemia. Antimicrob Agents Chemother. 2017;61:e01106–e01117. doi:10.1128/AAC.01106-17.
- Tang HJ, Chen CC, Lai CC, et al. In vitro and in vivo antibacterial activity of tigecycline against Vibrio vulnificus. J Microbiol Immunol Infect. 2018;51:76–81. doi:10.1016/j.jmii.2016.04.009.
- Lin YS, Hung MH, Chen CC, et al. Tigecycline salvage therapy for necrotizing fasciitis caused by Vibrio vulnificus: case report in a child. J Microbiol Immunol Infect. 2016;49:138–141. doi:10.1016/j.jmii.2013.04.008.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 32, 2019 - Issue 2
Case Studies
Late-onset Vibrio vulnificus septicemia without cirrhosis
Michelle T. LeeDepartment of Internal Medicine, University of Texas Health Science Center, Houston, Texas; Correspondence[email protected]
http://orcid.org/0000-0003-3854-1294
, MD, PharmD http://orcid.org/0000-0003-3854-1294, An Q. DinhDepartment of Internal Medicine, University of Texas Health Science Center, Houston, Texas; ;Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center, Houston, Texas; http://orcid.org/0000-0002-2965-9269
, BS http://orcid.org/0000-0002-2965-9269, Stephanie NguyenMcGovern Medical School, University of Texas Health Science Center, Houston, Texashttp://orcid.org/0000-0001-8945-4970
, BA http://orcid.org/0000-0001-8945-4970, Gus KruckeDepartment of Internal Medicine, University of Texas Health Science Center, Houston, Texas; http://orcid.org/0000-0001-8290-2478
, MD http://orcid.org/0000-0001-8290-2478 & Truc T. TranDepartment of Internal Medicine, University of Texas Health Science Center, Houston, Texas; ;Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center, Houston, Texas; http://orcid.org/0000-0002-2696-4196
, PharmD http://orcid.org/0000-0002-2696-4196